Trade BioNTech ^BNTX

Aberdeen Group plc Has $28.79 Million Stock Position in BioNTech SE Sponsored ADR $BNTX

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC

BioNtech Stock Forecast 2026-2030 | Future Outlook | Capital.com

Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus

BioNTech Hire Signals People Focus As Oncology Plans And Valuation Attract Attention

BioNTech (NASDAQ:BNTX) Cut to Market Perform at Leerink Partners - Zolmax

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy

BioNTech Adds Chief People Officer To Support Oncology Growth Plans

Assessing BioNTech (BNTX) Valuation After Goldman Sachs Buy Upgrade And Oncology Growth Focus

BioNTech (NASDAQ:BNTX) Rating Lowered to Market Perform at Leerink Partners

Africa's deep tech boom rests on a fragile research ecosystem

Lingohr Asset Management GmbH Acquires 40,821 Shares of BioNTech SE Sponsored ADR $BNTX

Privium Fund Management B.V. Acquires 8,013 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech SE Sponsored ADR $BNTX Shares Purchased by Lingohr Asset Management GmbH - Daily Political

BioNTech (NASDAQ:BNTX) vs. uniQure (NASDAQ:QURE) Critical Analysis - Daily Political

Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline

BioNTech Advances Oncology Focus With BNT324 Trial And Leadership Shift

Appointments and advancements for Jan. 29, 2026 | BioWorld

BioNTech SE (BNTX): A Bull Case Theory

BioNTech SE's (NASDAQ:BNTX) Price Is Right But Growth Is Lacking After Shares Rocket 26% - Simply Wall St News

Is BioNTech (BNTX) Pricing Reflect Its mRNA Pipeline Potential After Recent Share Price Gains

BioNTech Shares Surge in 2026 as Analysts See Further Upside

Lbp Am Sa Acquires 47,859 Shares of BioNTech SE Sponsored ADR $BNTX - Zolmax

BioNTech SE Sponsored ADR $BNTX Holdings Boosted by Lbp Am Sa

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Sector Gamma AS Has $2.74 Million Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech (BNTX) Is Up 6.4% After Expanding Late-Stage Oncology Pipeline Ambitions - Has The Bull Case Changed?

Baillie Gifford & Co. Lowers Position in BioNTech SE Sponsored ADR $BNTX

BioNTech (NASDAQ:BNTX) Earns Buy Rating from Berenberg Bank

US Stock Market Today: S&P 500 Futures Rise On Cooling Inflation And Housing Jitters - Simply Wall St News

BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss

BioNTech (NASDAQ:BNTX) Trading 7.5% Higher - Here's Why

Dividend Stocks and Investing: What are the most popular dividend stocks in 2026?

Bitcoin (BTCUSD) is seeing a modest rise: Is BTC about to reverse and head lower?

XLM Stellar Price Prediction: How High Can XLM/USD Go in 2026?

Alphabet (GOOG) stock is trading down: What’s happening with Alphabet Inc.?

Gold price forecast: XAU/USD remains under $5000, what’s next?

Investment for beginners 2026: Is now a good time to buy Vanguard S&P 500 ETF?

NIO stock is trading down today: What’s happening with Nio Inc?

CFD Trading & Markets: Which CFD trading apps are best for beginners in 2026?

Nvidia Stock Analysis: Is now a good time to buy the dip in NVDA stock?

Tata Gold analysis: How does Tata Gold ETF compare to Tata Gold share?

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift